The Loss Quarter That Hides IOC's Real Problem — and a 2-Year Fix
Revenue jumped 27% to ₹2.82 lakh crore, but the company reported a ₹1,141 crore loss. Strip out the ₹15,000 crore inventory gain, and organic loss is ~₹16,000 crore. The quality issue, paired with geopolitical margin suppression and uncertain government LPG compensation, makes this a 'wait for visibility' quarter.
-₹1,141 Cr
-116.8% YoY | NPM -0.4% vs +2.0% prior year
+₹15,000 Cr
Crude -₹3–4/bbl, FGD +₹15k Cr net
~-₹16,000 Cr
Without the revaluation, operational loss
On the headline, IOC reported a ₹1,141 crore loss. On closer reading, that loss was almost entirely offset by a ₹15,000 crore mark-to-market gain on finished goods inventory. The real organic loss — what the quarter actually delivered operationally — was roughly ₹16,000 crore. That gap between reported and organic is the entire story of earnings quality this quarter.
Where the loss came from
Three structural headwinds compressed margins below zero: First, geopolitical crude premium — landed cost peaked at $10/bbl above Brent during Middle East tensions; it has now moderated to $2–3/bbl, but remains above pre-war norms. Second, SAED suppression (Special Additional Excise Duty) — price controls cut gross refining margin (GRM) by approximately $20/bbl ($15.59 reported vs. $36/bbl SAED-adjusted). Third, LPG under-recovery — the company absorbed losses of ₹665 per cylinder in June, declining to ₹475 in July and expected to improve to ₹250 in Q2 (assuming Saudi crude price stabilizes). These three factors alone would have generated a loss in the ₹15,000–16,000 crore range. The inventory gain masked it.
Recent renewed military escalations in the middle east have once again brought the security of critical maritime energy corridors, particularly the Strait of Hormuz and Red Sea into sharp focus, reminding us that volatility remains an inherent feature of the global energy ecosystem.
Operationally, the quarter was strong: refining throughput hit 19.2 million metric tonnes at 109% utilization, fuel & loss ratio fell to 8.04% (the lowest since BS-VI standards), and pipeline throughput set a record at 28.5 MMT. The franchise is executing well. But profitability was decapitated by policy and geopolitical factors entirely outside management's control.
Management claims vs. what holds up
Strong operational footprint amid supply chain diversification
OverstatedRevenue +27% YoY achieved; throughput 19.2 MMT, 109% utilization. But PAT collapsed ₹6,800 Cr to a loss due to geopolitical margin compression, not execution weakness.
Inventory gains of ₹15k Cr mitigated quarter losses
SupportedConfirmed. Crude side loss ₹3–4/bbl, finished goods gain ₹15k Cr. Net offset helped absorb margin collapse.
GRM $15.59/bbl demonstrates refining strength
ContradictedReported $15.59 net of SAED. SAED-adjusted GRM $36/bbl — price controls suppressed earnings by ~$20/bbl.
Capex projects on track for Q4 CY26 completion
SupportedPanipat 94% done (target Dec 26), Gujarat 90% (Nov 26), Barauni 92% (Dec 26), PX-PTA 95% (next month). Timelines credible based on current trajectory.
LPG losses improving quarter-on-quarter
SupportedJune ₹665/cyl → July ₹475/cyl → Q2 expected ₹250/cyl. Trend positive, but losses remain severe and dependent on Saudi crude price stabilization.
What changed on this call — and why it matters
Capex roadmap crystallized. Five major projects totaling ₹90,000 crore (~$10 billion) are 94–95% complete and targeted for commissioning by end of calendar year 2026: Panipat expansion adds 10 MMTPA (₹38k Cr), Gujarat adds 4.3 MMTPA (₹19k Cr), Barauni adds 3 MMTPA (₹18k Cr), PX-PTA petrochemical complex (₹value not disclosed, 95% done), and polybutadiene rubber plant at Panipat (₹3k Cr). Combined, these add ~17 MMTPA to refining capacity, pushing throughput from 77 MMTPA in FY27 to 85 in FY28 and 90 by FY29. This is IOC's most detailed capex guidance yet.
Petrochemical intensity strategy defined. The company committed to raising petrochemical revenue intensity from 6.5% to 15% over 5–6 years via ₹100,000 crore of capex. This is a strategic shift away from refining-only toward integrated hydrocarbons — LAB (linear alkyl benzene), PX-PTA (paraxylene & purified terephthalic acid), polybutadiene, and others. It's a long-term play to capture downstream margin and diversify earnings.
Renewable energy scale articulated. Terra Clean, IOC's renewable subsidiary, has 2.65 GW approved for transmission, 4–5 GW in progress, and a target of 18 GW within 3–4 years. Land allotted in UP (423 acres) and Gujarat (100 MW wind). Concrete execution roadmap, not aspirational messaging.
Crude sourcing reconfigured. Spot sourcing jumped from 50% (pre-war) to 84% (now) due to Middle East disruptions. Sourcing mix diversified: Russia 50–54%, Brazil, Africa, USA. Peak landed cost premium was $10/bbl; now $2–3/bbl. Geopolitical hedging evident, but exposure remains.
Revenue growth 27% YoY, +19% QoQ; demand resilient (MS +7%, HSD +5%, pipeline 28.5 MMT record)
Refining operational excellence: 8.04% fuel & loss (lowest post-BS-VI), 109% throughput utilization
Capex roadmap credible: 5 projects ₹90k Cr (90–95% done), Q4 CY26 target, adds 17 MMTPA
Petchem/renewable strategy multi-year differentiation (6.5%→15% intensity, 18 GW target)
Reported loss ₹1,141 Cr with ₹15k Cr inventory gain masking ~₹16k Cr organic loss
SAED suppression (~$20/bbl GRM impact) and LPG under-recovery (₹665/cyl) are structural, not transitory
LPG government compensation 'based on past practice' — timing/quantum uncertain, material earnings driver
Capex ramp (₹100k Cr petchem + renewables) strains balance sheet; debt-equity 0.71, borrowings up ₹30.8k Cr in FQ
Petchem expansion timed during weak cycle; naphtha-based plants typically have subpar economics
Management unable to predict GRM recovery timing; margin recovery depends on external commodity prices
Risks, ranked by severity to a holder
LPG government compensation timing/quantum
HIGHUnder-recovery absorbs ~₹700 Cr/month; management cites 'past practice' but has no formal commitment. Policy risk dominates near-term PAT visibility. If compensation is delayed or truncated, FY27–28 earnings remain depressed.
Inventory valuation volatility & earnings quality
HIGHThis quarter, ₹15k Cr finished goods MTM gain masked operational weakness. If crude/product prices reverse sharply, the gain flips to loss + new losses. Crude inventory marked $83/bbl vs. Bloomberg $70 — discrepancy unresolved, raises valuation transparency concerns.
Geopolitical margin compression persistence
HIGHSAED suppresses GRM by ~$20/bbl (structural policy, no relief timeline). Crude premium $2–3/bbl still elevated; Red Sea/Strait volatility ongoing. No levers to restore margin until policy changes (unlikely near-term).
Capex project execution delays
MEDIUM-HIGH5 projects 94–95% complete, targeted Q4 CY26. Even 2–3 month slip delays margin recovery by a quarter+ and pushes earnings accretion into FY29. Slippage would kill the bull case for 2–3 years.
Petchem cycle downturn risk
MEDIUMExpansion ₹100k Cr over 5–6 yrs during weak petchem cycle. Naphtha-based plants typically have subpar economics. If cycle recovery delays, utilization and margins weak; ROI stretched.
Crude price/inventory reversal
MEDIUMCurrent environment highly volatile. Sudden price fall could flip ₹15k Cr gain to loss. Working capital swings could drive unpredictable earnings volatility until prices stabilize.
How the street is positioned — and what it tells us
Price action: The day-1 pop was +2.52% on announcement (Jul 31, 2026); by day-5, it held at +2.29%. A modest hold, suggesting the street read the result as 'on-line, not a miss' but not compelling. The stock now trades at ₹137.8, down 27% from its all-time high of ₹188.96. It sits below its 20-day, 50-day, and 200-day moving averages (₹140.93, ₹141.16, ₹152.52 respectively) — all bearish signals. RSI at 43.9 is neutral (no oversold bounce). The stock is not in favor.
Ownership flow: FII stake declined 77 basis points QoQ (9.85% → 9.08%); DII upticked 41 basis points (9.21% → 9.62%). The FII trim during earnings season is a soft negative — foreign money is showing discipline, trimming losers or maintaining allocations amid uncertainty. DII uptick (domestic mutual funds, insurance) is modest support but insufficient to offset the FII exit. Promoter stake unchanged at 51.50%.
Valuation context: The 27% drawdown from ATH reflects the consensus view: earnings are in a trough for 2 years (geopolitical/policy squeeze), capex is a bet-the-farm commitment (₹100k Cr petchem + renewables), and near-term PAT is clouded by inventory-dependent quality and government compensation uncertainty. The stock's positioning below all key moving averages + FII trim signal conviction that the pain extends through FY27–28 before capex accretion shows up. The street is RIGHT to be cautious.
What to watch next
1 · Q2 FY27 LPG under-recovery trajectory (next 4 weeks)
Expected ₹250/cyl average (down from ₹665 June). More important: does the government announce LPG compensation? If yes, timing and quantum become the read. If no announcement, the bear case extends — FY27–28 remain loss-making, capex thesis gets a 2-year extension.
2 · Capex project commissioning milestones (Nov–Dec 2026)
Panipat (Dec), Gujarat (Nov), Barauni (Dec) all targeted for Q4 CY26. If timelines hold, new units should phase in at Q3–Q4 FY27. If slippage, margin recovery story gets pushed to FY28 Q1+, and capex thesis loses momentum.
3 · GRM & margin recovery trajectory (Q3–Q4 FY27)
New refining units should contribute higher-yielding value-added products, lifting both GRM and operating margin. Watch whether OPM recovers toward 3–4% (prior year was 2.6% even with SAED in effect). If GRM stays suppressed despite new capacity, the capex story weakens significantly.
4 · Crude price stability & geopolitical relief (ongoing)
Strait of Hormuz and Red Sea disruptions remain active. If stability returns (crude $80–85/bbl steady), sourcing costs normalize and margins begin recovery. This is the highest-uncertainty variable — drives both LPG under-recovery and crude premium.
IOC is a franchise in transition: from earnings-stable refining to a diversified energy portfolio (refining + petchem + renewables + gas). That multi-year bull case is real and the capex roadmap is credible. But the transition is happening during a geopolitical and policy storm — SAED price controls suppress refining margins by $20/bbl, LPG under-recovery is absorbing ₹700+ crore per month, and crude volatility creates working capital whiplash. The reported Q1 loss, with ₹15k crore in inventory gains masking ~₹16k crore of organic loss, is a step-back quarter, not a step-forward one.
The strategic roadmap is intact and execution is on track (capex 94–95% done, throughput ramp credible). But earnings visibility is poor. The stock's 27% drawdown from all-time high is not panic — it's the market pricing in 2 years of pain (FY27–28) before capex accretion and margin recovery show up in FY28 onwards. For holders, this is a 'Hold and wait for LPG compensation + capex commissioning' story. For new capital, it's a 'wait for visibility' — the risk-reward doesn't turn until we see Q2 LPG trends and government support clarity.
The number to track from here: Government LPG compensation announcement (timing + quantum). If ₹3–5k crore is sanctioned for FY27, the loss story moderates materially and the capex thesis gets a hearing. If it's delayed or truncated, the near-term remains a loss-making hold and the stock will likely retest lower levels. The catalyst is policy, not operations.
Strong refining growth masked by LPG losses and margin compression
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Revenue growth 27.1% YoY achieved; PAT collapsed due to geopolitical/policy factors, not guidance miss (none given). Project execution on track (94–95% complete by plan). No prior numeric guidance to grade.
Cautiously Optimistic
next 1–2 quarters
Very Optimistic
multi-year
Strong strategic roadmap (₹90k Cr capex, 18 GW renewables, petchem intensity 6.5%→15%) credible on execution track, but delivered Q1 loss (₹1,141 Cr, NPM -0.4%) exposes acute near-term vulnerability. LPG under-recovery and policy-induced margin compression (SAED) are structural headwinds; company dependent on government compensation. Risk is that capex ramp + delayed margin recovery + sustained margin pressure cap upside for 2 years.
₹281933.1 Cr
Revenue · +27.1% YoY₹-1141.1 Cr
Reported PAT · −116.8% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Strong operational footprint amid supply chain diversification
OVERSTATEDRevenue +27.1% YoY, but PAT collapsed ₹6.8k Cr to loss due to geopolitical margin compression
Inventory gains of ₹15k Cr mitigated quarter losses
METConfirmed: ₹15k Cr gain on finished goods; ₹3–4/bbl loss on crude; net helped offset operational weakness
GRM $15.59/bbl demonstrates refining strength
MISS$15.59 reported, but SAED-adjusted $36/bbl; price controls suppressed earnings by ~$20/bbl
Capex projects on track for Q4 CY26 completion
METPanipat 94% done (Dec 26), Gujarat 90% (Nov 26), Barauni 92% (Dec 26), PX-PTA 95% (next month); timelines credible
LPG losses improving quarter-on-quarter
METJune ₹665/cyl → July ₹475/cyl → Q2 expected ₹250/cyl; trend positive but losses remain severe and geopolitical-dependent
Earnings quality
What changed since the last call
Capex roadmap detail expanded
NewDetailed 5-project schedule (₹90k Cr, 94–95% complete) with timelines: Panipat Dec 26, Gujarat Nov 26, Barauni Dec 26, PX-PTA Sept, polybutadiene Dec 26. Throughput targets: FY27 77, FY28 85, FY29 90 MMTPA. New from this call.
Petchem intensity target articulated
NewExplicit 5–6 year plan to raise petchem from 6.5% to 15% revenue intensity; ₹100k Cr capex; projects on LAB, PX-PTA, others. Multi-year strategic shift, not incremental.
Renewable energy scale defined
NewTerra Clean Ltd. target 18 GW in 3–4 years; 4–5 GW in progress; land allotted (423 acres UP, Gujarat wind 100 MW). Concrete expansion roadmap versus prior aspirational tone.
LPG loss trajectory transparency
NewMonth-wise LPG under-recovery revealed: June ₹665/cyl, July ₹475, Q2 expected ₹250. Shows improvement trend and sensitivity to Saudi CP (790→592→632). New quantified visibility.
Crude sourcing strategy materialized
UpgradeSpot sourcing jumped 50% → 84% due to ME disruption. Diversification to Russia (50–54%), Brazil, Africa, USA executed. Procurement cost $10/bbl premium at peak, now $2–3. Hedging geopolitical exposure vs prior quarter.
The Q&A
Moderate. Analysts pressed on near-term margin recovery (GRM outlook), capex prudence (debt concerns), petchem hurdle rates, and inventory-driven earnings quality. Management held strategic line but admitted uncertainty: 'GRM will depend on play between crude/product prices, cannot predict'; declined yield specifics ('I can't give the specific number'). No defensive evasion detected; acknowledged LPG losses and government dependency as material headwinds. One unresolved discrepancy: crude inventory marked ₹83/bbl June 30 vs Bloomberg $70—noted but sidestepped.
Capital allocation post-expansion — Probal Sen, ICICI Securities
AnsweredCapex remains 30–40k Cr/yr next 2–3 yrs. Petchem ₹100k Cr over 5–6 yrs (6.5%→15% intensity), renewables 18 GW in 3–4 yrs, biofuels, shipping, battery swapping. Not exclusively renewables; diversified.
GRM and SAED impact — Probal Sen, ICICI Securities
AnsweredSAED-inclusive GRM ~$36/bbl. Difference $20+/bbl is suppression due to price controls.
LPG under-recovery trajectory — Probal Sen, ICICI Securities
AnsweredJune ₹665/cyl, July ₹475, August declining due to Saudi CP fall (796→592). Q2 expected ₹250 avg, assuming Saudi CP stabilizes. Geopolitical dependent; trend improving but uncertain.
Inventory impact on GRM & marketing — Sabri Hazarika, Emkay Global
AnsweredCrude side: $3–4/bbl loss. Finished goods: ₹15k Cr gain (large inventory base). Gains offset losses this quarter. Confirms margin suppression without inventory support.
Project contribution timing and GRM escalation — Sabri Hazarika, Emkay Global
PartialQ3 FY26–27 commissioning. GRM will depend on crude/product price play; cannot predict. New units produce more value-added products, which will boost margins, but no specific number given.
Yield improvement post-expansion — Nitin Tiwari, PhillipCapital
PartialCannot give specific number, but new modern units enable higher value-added product processing; returns 'definitely going to go up.' No quantified target.
Pricing policy and LPG compensation — Nitin Tiwari, PhillipCapital
PartialSituation very dynamic, day-to-day. Engaged with authorities. Hopeful on LPG government support based on past practice; timing/quantum uncertain. Other products depend on multiple factors (crude, spreads, forex, insurance, inventory). No commitments.
Crude landed cost buildup — Vivekanand, Ambit Capital
AnsweredPre-war: Brent -$1/2. War peak: $10/bbl premium. July: $2–3. All-inclusive (shipping/logistics). Overall impact $10/bbl on portfolio. Ongoing volatility.
Supply chain JV and sourcing diversification — Vivekanand, Ambit Capital
AnsweredMoU signed Sept 19 (non-binding). IOC to explore 4 MR vessels as starter in JV. Tenders already out. Diversification achieved: ME main source, but significantly increased Russia, West Africa, Venezuela, Brazil, USA spot. Strategy working—managed cost despite disruption.
Ethanol blending commitment — Keshav Soni, Kotak Bank
Answered20% blending target achieved, in line with other OMCs. Different ethanol types priced independently; basket-based on MS blend. Not flexible on government target; collective decision across 3 OMCs. 20% achieved; whatever new target given, achievable.
OMC loss guidance vs actual outcome — Keshav Soni, Kotak Bank
AnsweredExcise duty reduction, multiple price tranches, June price decline (initial estimate April), all 3 OMCs had inventory gains. Factors combined to mitigate.
Borrowing levels and debt stress — Sanjay Mookim, JP Morgan
PartialBorrowings up ₹31k Cr (March ₹110.7k → June ₹141.5k). Not distressed; banking arrangements in place at competitive rates. Debt-equity 0.71, net 0.51. Strong balance sheet. Interest cost did rise vs pre-war, but manageable.
Inventory accounting discrepancy — Sanjay Mookim, JP Morgan
DodgedComparison on Ind-AS marked-to-market basis. Inventory $87 March 31 → $83 June 30 = marginal loss. Finished goods had gains due to product price rises. [Discrepancy noted but not fully resolved.]
Capex prudence and balance sheet stress — Saurabh Handa, Citigroup
AnsweredIOC energy basket share 9–10%; must maintain via investment. All capex project-evaluated on profitability. Refining gave extraordinary returns 4–5 yrs; petchem will too. Renewables will be major next 3–4 yrs. No target capex; each deal on merits. 30–40k Cr/yr is expected range, not cut.
SPR facility participation — Saurabh Handa, Citigroup
AnsweredSPR capacity 5.33 MMT (Vizag, Mangalore, Padur), target 11.83 MMT. Not IOC-specific; sector-wide. IOC under discussion for participation if commercially viable. No formal directive; all evaluated on commercial terms.
Refining margin escalation from new units — Saurabh Handa, Citigroup
PartialDistillate yield, fuel & loss depend on crude type. New units improving both. Fuel & loss only 8% this quarter (lowest post-BS-VI). SPRINT targets quartile-1 in Solomon study. Value-added products will increase margins; no specific quantification.
ATF demand and PSF scheme uptake — Sarthak Tita, DSP Asset Managers
AnsweredNo airlines used PSF (prices fell before activation). International pricing passed to airlines. Domestic negotiated pricing ongoing. Current domestic scheduled airline pricing ₹115/liter (dynamic, recent cycle ₹110; previous ₹115). Market-linked.
Project completion timelines and throughput targets — Kishan Mundhra, DAM Capital
AnsweredPanipat 15→25 MMTPA (₹38k Cr, 94% done, Dec 26). Gujarat 13.7→18 MMTPA (₹19k Cr, 90%, Nov 26). Barauni 6→9 MMTPA (₹18k Cr, 92%, Dec 26). PX-PTA (95%, next ~1 mo). Polybutadiene ₹3k Cr (Dec 26). Total 5 projects ₹90k Cr (~$10B). FY27: 77 MMTPA, FY28: 85 MMTPA, FY29: 90 MMTPA.
Petchem expansion strategy and scale — Kishan Mundhra, DAM Capital
AnsweredEnhance petchem capacity +5 MMTPA (LAB, PX-PTA, others). Cost ₹100k Cr over 5–6 yrs. Intensity 6.5%→15%. All projects start/complete by March 30 (some 5–6 mo variance). Open to gas-based, naphtha-based inputs.
Ethanol blending flexibility — Bineet Banka, Nomura
DodgedNot flexible on government target; collective decision with 3 OMCs. Cannot give futuristic statements. Whatever target given (now 20%), we achieve comfortably.
Petchem hurdle rates and cycle risk — Bineet Banka, Nomura
PartialAll capex passes hurdle rate. Petchem cyclical; 1–2 good years in any cycle recover costs. Demand huge in India (imports). Natural integration with refining. Long-term strategy; IOC scale advantage. Refining returns extraordinary; expect petchem to deliver similarly.
Crude sourcing: long-term vs spot mix — Vivekanand, Ambit Capital (2nd)
AnsweredPre-war: 50/50 spot/term. Now: 84% spot (ME disruption). Spot from non-ME regions. Dynamic daily. Pricing month-to-month; no single premium/discount. Managed cost well even at peak war; still higher than pre-war.
Project SPRINT cost-saving progress — Vivekanand, Ambit Capital (2nd)
AnsweredSPRINT saved ₹2k Cr FY26. SPRINT 2 expecting ₹2–2.5k Cr FY27. Not just cost; covers efficiency, market share, logistics, opex. On track despite war. Tracking each opex/capex to optimize.
US sanctions on Russian/Iranian crude — Vivekanand, Ambit Capital (2nd)
AnsweredBill passed Senate, not yet law. Must clear House, be signed by President. Not yet implemented. Tracking developments; will mitigate once implemented.
Guidance
FY27 throughput ~77 MMTPA, FY28 85 MMTPA, FY29 90 MMTPA (refining)
HighBased on 5 projects 90–95% complete, commissioned Q4 CY26 (Nov–Dec 26). Panipat +10, Gujarat +4.3, Barauni +3 MMTPA adds ~17 MMTA. Sequential build credible on current trajectory.
Petchem capex ₹100k Cr over 5–6 yrs; intensity 6.5%→15%
MediumLong-term strategic shift. Projects at various approval stages. 5 MMTPA capacity addition planned. Cyclical petchem market; management confident 1–2 good years recover cost, but execution risk on timing/ROI.
Renewable energy 18 GW in 3–4 yrs (Terra Clean subsidiary)
Medium2.65 GW transmission approval received; 4–5 GW in progress; 100 MW wind (Gujarat), ~100 MW solar (UP 423 acres). Greenfield expansion; depends on project approvals, capex execution.
GRM dependent on crude/product price spreads; cannot predict
LowManagement declined to quantify GRM escalation post-projects. Refining margin benefit depends on external commodity prices. SAED discount ~$20/bbl; extent of relief unclear.
LPG under-recovery expected ₹250/cyl average Q2 FY27 (from ₹665 June)
MediumTrend improving (June→July→Aug decline), but government compensation timing/quantum uncertain. Geopolitical sensitive (Saudi CP movements, Red Sea disruption). ₹250 assumes stable Saudi CP.
Yield improvement from new refining units; no specific target
MediumManagement expects higher distillate yield and lower fuel & loss post-projects, driven by value-added product capacity. No quantified yield target beyond 'mid-80s possible' (analyst suggestion, not committed).
FY27 capex ₹32,700 Cr budgeted; FY28–29 expected 30–40k Cr/yr
HighQ1 FY27 capex ₹6,461 Cr (on pace). Breakdown: ₹38k Cr Panipat, ₹19k Cr Gujarat, ₹18k Cr Barauni, ₹3k Cr polybutadiene, plus petchem ₹100k Cr over 5–6 yrs, renewables 18 GW (cost TBD).
Risks the call surfaced
Geopolitical margin compression
HighCrude landed cost $10/bbl premium at peak war. SAED suppresses GRM ~$20/bbl. Spot sourcing 84% exposes to daily commodity volatility. Red Sea/Strait disruption ongoing.
LPG under-recovery dependency on government
HighLPG loss ₹665/cyl (June), declining to ₹250 expected (Q2). Depends on government compensation timing/quantum. No formal commitment. Absorption into PAT material (~₹700 Cr per month per analyst estimate).
Capex execution risk
Medium5 projects ₹90k Cr (₹10B) targeted Q4 CY26: Panipat (Dec 26, 94% done), Gujarat (Nov 26, 90%), Barauni (Dec 26, 92%), PX-PTA (~1 mo, 95%), polybutadiene (Dec 26). 2–3 month slip delays margin recovery by a quarter.
Inventory valuation volatility
MediumFQ finished goods inventory gain ₹15k Cr (price revaluation). Crude inventory marked $83/bbl June 30 (vs Bloomberg $70—discrepancy unresolved). If prices fall sharply, reversal of ₹15k Cr gain + new losses possible.
Petchem cycle downturn risk
MediumPetchem capex ₹100k Cr over 5–6 yrs to lift intensity 6.5%→15%. Current cycle weak; analyst (Bineet Banka, Nomura) noted naphtha-based plants have 'subpar economics.' Expansion timed at cycle bottom (favorable), but 2–3 year cycle recovery uncertain.
Management
Score 7/10. Clear on strategic roadmap and operational metrics. Transparent on LPG losses (₹665→₹250/cyl trajectory), inventory impacts, and margin suppression (SAED ~$20/bbl). Some hedging on GRM/margin outlook ('cannot predict'). One unresolved discrepancy on crude inventory pricing ($83 vs Bloomberg $70). Project execution track record strong: 5 capex projects 90–95% complete, targeted Q4 CY26. Refining fuel & loss 8.04% (best post-BS-VI); operational discipline evident. Capex on schedule. Delivered revenue growth 27.1% YoY as expected; PAT loss due to external geopolitical/policy factors, not execution miss.
1 · Nov–Dec 2026
Panipat, Gujarat, Barauni refinery expansions commission; PX-PTA petchem plant expected Sept
2 · Q3–Q4 FY27
Refining capacity adds ~17 MMTPA; throughput step to 77 MMTPA; GRM & yield improvement phase-in
3 · FY28 onwards
Petrochemical intensity ramp (6.5%→15% over 5–6 yrs); 5 MMTPA petchem capex begins contribution; SPRINT 2 cost savings ₹2–2.5k Cr
Risk is that capex ramp + delayed margin recovery + sustained margin pressure cap upside for 2 years.
Margins Under Pressure: Commodity Headwinds Outweigh Refinery Strength
IOC faces Q1 headwinds from high crude, weak rupee, and inventory losses despite record refining margins. Street watches for when commodity tailwinds return.
The Setup: Indian Oil enters Q1 FY27 amid a classic refiner's paradox. While the company operates world-class assets—FY26 set a record 75.4 MMT crude throughput with 99.5% reliability—Q1 earnings will be penalized by three headwinds: elevated Brent crude (~$80+/bbl range in H1 2026), rupee weakness, and inventory losses that upstream crude acquisition costs have not yet flushed through the P&L. Refining crack margins hit record territory, but that gain is drowning in the sheer volume of high-cost inventory. Brokerages have cut FY27E EBITDA by 39%, with the bulk of the pain expected in this quarter.
depressed YoY
High crude + weak rupee + inventory loss expected to offset refining margin gains; brokerages see Q1 as the cycle trough
record highs
On-plan for FY26 trajectory; benefiting from tight global supply; insufficient to cover input cost burden
~19 MMT expected
On-plan with FY26 avg; operational stability intact; refinery expansions come post-Q1
₹50–100 Cr headwind
INR weakened Q4 → Q1 2026 vs. assumptions; derivative loss on forex exposure likely
What a strong Q1 vs. weak print looks like: A strong Q1 would show EBITDA/net profit above brokerage trough forecasts, signalling margin resilience or faster-than-expected cost absorption; buyback/capital deployment resilience. A weak Q1 would confirm the inventory loss drag, push net profit into negative territory (or single-digit %), and trigger further FY27E cuts if crude averages remain sticky—or if management signals delayed recovery into Q2. The Street is priced for weakness; any upside from margin strength or lower-than-expected forex drag could see tactical relief.
On Track for FY27?
IOC has no issued full-year guidance for FY27, but the brokerage consensus (down 39% vs. pre-Q1 assumptions) now embeds ~₹8,000–8,500 Cr net profit for the year vs. FY26's ~₹18,000+ Cr—a heavy cut driven entirely by Q1 commodity stress. Management's prior statements on refinery expansion (100 KTPA Paradip SAF JV approved May 2026; 60%/80%/100% utilization in Years 1–3 post-commission) and capex discipline suggest confidence in long-cycle projects, but near-term guidance will hinge on crude/rupee stabilisation by Q2. The company's 75.4 MMT FY26 throughput—up 5% YoY and world-class for reliability—is a foundation; Q1 should maintain that run-rate, anchoring volume expectations.
Since Last Quarter
Jul 17, 2026
Board Meeting scheduled July 31 to approve Q1 FY27 unaudited results
Routine; report date confirmed
Jul 15, 2026
TDS notification on final dividend (FY26)
Routine; confirms ₹1.25/share (12.5%) payout underway
Jul 1, 2026
Trading window closed for insiders (SEBI compliance)
Routine; standard pre-result blackout
Jun 30, 2026
Record date set for ₹1.25 final dividend (Aug 14, 2026)
Positive; capital return underway; stable dividend signal
Jun 25, 2026
Insider trading window closed from July 1
Routine; blackout in place
Jun 5, 2026
A. Amarnath appointed Government Nominee Director
Routine; regulatory board appointment; no governance concern
May 18, 2026
SAF JV approved with M11 Energy (50:50) for ₹1,063.6 Cr Paradip project (100 KTPA HEFA)
Strategic; energy transition play; capex neutral to FY27–28 cash flow
May 18, 2026
FY26 final dividend ₹1.25/share approved; full-year dividend ₹2.50/share (25% payout ratio)
Positive; disciplined capital allocation; supports valuation floor
Apr 27, 2026
Hydrocarbon discovery in Libya (Block 95/96, Ghadames Basin; 25% stake in consortium)
Upside optionality; exploration play; minimal near-term P&L impact
Apr 1, 2026
FY26 operational record: 75.4 MMT throughput; 99.5% reliability; Dr. Alok Sharma retired from Board
Positive operations; routine board transition
Summary: No material corporate actions that would alter Q1 trajectory. Dividend payout (₹1.25/share final, record Aug 14) is routine and supports disciplined shareholder return. SAF JV and Libya exploration are capital-light optionality. Board succession (Amarnath appointment) is governance-routine. The focus remains squarely on operational execution (throughput) and commodity headwinds (crude, rupee) in the quarter itself.
1 · EBITDA & Net Profit vs. Trough Forecasts
Brokerages expect ₹3,500–4,500 Cr EBITDA for Q1 (vs. FY26Q4's ~₹10,000 Cr); net profit in low single digits or a small loss (~₹100–200 Cr). Any Q1 net profit >₹500 Cr would signal better-than-expected margin hold or faster inventory absorption; <₹(200) Cr would confirm the downside case and likely trigger further FY27 cuts. Management will guide on when they see recovery (Q2 vs. H2).
2 · Crack Spread & Refining Margin Disclosure
IOC will disclose realised crack margins (bbl or ₹/bbl basis). If margins remain at record levels but get offset by inventory/forex, management commentary on when higher-margin barrels flow through profit will be key. Any hint of margin normalisation post-Q1 is a recovery signal.
3 · Throughput & Operational Reliability
Expect Q1 throughput guidance for FY27 (should be ~18–19 MMT) and any flags on the upcoming refinery expansions (Paradip SAF JV commissioning timeline, capex run-rate). Operational momentum (if throughput guidance holds) gives confidence in volume anchor.
4 · Forex/Inventory Loss Quantification
Management will need to articulate Q1 one-off losses (inventory revaluation, derivative losses). If the quantum is lower than feared, it signals better-than-expected operational hedging; if higher, it reinforces commodity sensitivity for the rest of FY27. Listen for any forward-looking hedging strategy.
5 · FY27 Guidance & Capex Intent
No formal FY27 guidance is likely (typical for IOC), but management may telegraph Q2–Q3 expectations (when crude/rupee stabilise). Capex commentary (SAF JV ramp, refinery expansions, M&A appetite) signals confidence. Dividend sustainability discussion anchors downside risk.
The Bottom Line: Q1 FY27 is a cycle trough engineered by commodity headwinds, not operational failure. IOC's refinery assets are world-class (75.4 MMT FY26, 99.5% uptime), margins are at record levels, and the company is investing in energy transition (SAF JV). The catch: high crude prices, rupee weakness, and inventory losses will likely suppress net profit to a fraction of FY26 or a loss, justifying the Street's 39% EBITDA cut. The stock is priced for weakness (down 26% from ATH, neutral consensus). Result day will confirm the magnitude of Q1 pain and—critically—management's conviction on recovery timing. If crude normalises by August and the company signals Q2 recovery, the setup becomes 'buy the dip on cycle'. If crude stays sticky and guidance sours, FY27 EBITDA could fall further, warranting another round of cuts. Neutral is fair until that clarity emerges.
IndianOil swings to ₹1,141 Cr Q1 loss on inventory hit, weak margins — far shallower than feared
PAT -116.76% YoY · revenue +27.08% · margins compressing · beat vs street
₹2,81,933.07 Cr
+27.08% YoY
₹-1,141.09 Cr
-116.76% YoY
-0.4%
-3.5pp YoY
₹-1.18
Indian Oil Corporation swung to a consolidated net loss of ₹1,141 Cr in Q1 FY27 (loss attributable to shareholders ₹1,631 Cr, EPS −₹1.18), reversing a ₹6,808 Cr profit a year ago and a ₹15,176 Cr profit in the March quarter. On a standalone basis the loss was deeper at ₹2,662 Cr (EPS −₹1.93); the consolidated figure is cushioned by ₹697 Cr of associate/JV profit (Petronet LNG, CPCL and others) — both bases tell the same loss story, so the divergence is one of degree, not direction. Revenue from operations rose to ₹2,81,933 Cr, up 27.1% YoY and 19.0% QoQ, lifted by elevated fuel prices — but topline growth was irrelevant to the result: this was a margin quarter.
Q1 FY-2027 vs prior quarters
The loss sits on the operating line. Consolidated operating margin collapsed to 0.12% from 4.61% a year ago and 8.40% in Q4, and net profit margin turned negative at −0.40%. The squeeze reflects the classic OMC combination management and street both flagged — adverse inventory losses as crude moved, thin fuel marketing margins, and continued LPG under-recoveries. Cost of materials consumed near-doubled to ₹1,95,318 Cr (from ₹1,09,451 Cr YoY), only partly offset by a ₹21,590 Cr inventory build. The company still carries a cumulative net negative LPG buffer of ₹29,729.95 Cr; it recognised ₹3,621.51 Cr of the government's ₹14,486 Cr LPG compensation as revenue this quarter (disbursed in 12 monthly instalments), which modestly aided the topline.
The stock went into the print at ₹140.17, down 1% over the past month of trading.
For context: revenue is at a 6-quarter high.
Against expectations, this is a beat on a bad quarter. Zee Business Research had previewed a net loss of around ₹15,887 Cr on weak marketing margins and LPG under-recoveries; the actual print — a consolidated loss of ₹1,141 Cr and standalone ₹2,662 Cr — is a fraction of that, meaning the marketing/inventory hit was far milder than the market braced for. The company gives no formal earnings guidance, so there is no management outlook to measure against. Concurrent corporate actions were routine-to-positive: a ₹1.25 final dividend (record date Aug 14) and the ₹64,500 Cr Paradip refinery investment underline the capex cycle continues despite the soft quarter. One governance overhang persists — IOC has had no Independent Directors since 28 March 2026 and its Audit Committee stands discontinued, so these results were reviewed and approved by the Board alone.
W1
Marketing/refining margin recovery: operating margin fell to 0.12% consolidated — watch if Q2 restores toward the 4-8% range as crude stabilises
W2
LPG under-recovery drag: net-negative buffer ₹29,729.95 Cr; pace of the ₹14,486 Cr compensation (₹3,621.51 Cr/qtr run-rate) reducing it
W3
Board reconstitution: no Independent Directors since 28-Mar-2026 and Audit Committee discontinued — timeline to restore compliance
Clean digital filing. Consolidated PBT includes +₹697.13 Cr share of associates/JVs; net loss for period ₹1,141.09 Cr, of which loss attributable to owners is ₹1,630.74 Cr after +₹489.65 Cr non-controlling interest. No exceptional items. Governance flag: no Independent Directors since 28-Mar-2026, Audit Committee discontinued.